drugset / Trial / NCT03496545

Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury

NCT03496545

Phase 1/2 Completed 47 enrolled University of California, San Francisco
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the antipyretic effect of bromocriptine in critically-ill patients with acute neurologic injury and fever from infectious and non-infectious etiologies.

Timeline

Start
2018-11-30
Primary completion
2019-11-02
Completion
2019-11-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromocriptine Small molecule 5 mg Oral
Background Acetaminophen Small molecule 650 mg Oral